For help on how to get the results you want, see our search tips.
122 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
-
List item
Referral: Diflucan
fluconazole, associated names: Fluconazole, Fungustatin, Fungata, Triflucan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 02/09/2011, Last updated: 02/02/2012 -
List item
Referral: Diovan
valsartan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/11/2008, EC decision date: 16/02/2009, Last updated: 13/03/2009 -
List item
Referral: Diovan Comp
valsartan and hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/03/2009, EC decision date: 26/05/2009, Last updated: 11/06/2009 -
List item
Referral: Durogesic and associated names
fentanyl, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/07/2016, EC decision date: 22/09/2016, Last updated: 19/10/2016 -
List item
Referral: Ecazide
captopril/hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/04/2002, EC decision date: 22/08/2002, Last updated: 19/09/2002 -
List item
Referral: Efexor
venlafaxine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 28/11/2008, Last updated: 18/12/2008 -
List item
Referral: Efexor depot
venlafaxine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 28/11/2008, Last updated: 20/12/2008 -
List item
Referral: EMLA cream and associated names
lidocaine / prilocaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/09/2014, EC decision date: 28/11/2014, Last updated: 15/01/2015 -
List item
Referral: Ethinylestradiol-Drospirenone 24+4
ethinylestradiol / drospirenone, associated names: Yaz 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 06/07/2012, Last updated: 11/01/2013 -
List item
Referral: Etopophos
etoposide phosphate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2017, EC decision date: 26/06/2017, Last updated: 14/07/2017 -
List item
Referral: Extraneal
icodextrin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 20/01/2010, Last updated: 27/10/2009 -
List item
Referral: Famvir
famciclovir, associated names: Famciclovir-Sandoz, Famciclovir-SB, Famciclovir-SB Zoster, Famvir Zoster and Oravir, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 27/07/2010, Last updated: 09/09/2011 -
List item
Referral: Femara
letrozole, associated names: Femar, Fémara, Loxifan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/03/2012, EC decision date: 22/05/2012, Last updated: 12/06/2012 -
List item
Referral: Fenspiride containing medicinal products
fenspiride, Article 107i procedures
Status: CMDh final position, opinion/position date: 29/05/2019, Last updated: 26/06/2019 -
List item
Referral: Flolan
epoprostenol, associated names: Epoprostenol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 08/08/2012, Last updated: 14/09/2012 -
List item
Referral: Floxyfral
fluvoxamine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/01/2002, EC decision date: 30/05/2002, Last updated: 25/07/2002 -
List item
Referral: Flupirtine-containing medicines
flupirtine, Article 107i procedures
Status: European Commission final decision, opinion/position date: 26/06/2013, EC decision date: 05/09/2013, Last updated: 21/11/2013 -
List item
Referral: Fortum
ceftazidime, associated names: Cefortam, Glazidim, Panzim, Solvetan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 13/01/2011, Last updated: 22/10/2010 -
List item
Referral: Engerix B
recombinant hepatitis B vaccine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 13/04/2000, EC decision date: 28/08/2000, Last updated: 28/08/2000 -
List item
Referral: Gemzar
gemcitabine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 23/09/2008, Last updated: 06/10/2008 -
List item
Referral: Genotropin
Somatropin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2003, EC decision date: 26/06/2003, Last updated: 29/08/2003 -
List item
Referral: Genotropin
somatropin, associated names: Genotonorm, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 02/09/2010, Last updated: 26/04/2011 -
List item
Referral: Glucophage/Glucophage Forte/Risidon/Dianben
metformin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/10/2000, EC decision date: 06/02/2001, Last updated: 07/02/2001 -
List item
Referral: Haldol and associated names
haloperidol, associated names: Aloperidin, Haldol-Janssen, Serenase, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 28/04/2017, Last updated: 05/05/2017 -
List item
Referral: Haldol Decanoate and associated names
haloperidol decanoate, associated names: Haldol Decanoat, Haldol Decanoas, Serenase Dekanoat, Serenase Depot, Haldol - Janssen Decanoat Depot, Haldol Decanoato, Haldol Depot, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 28/04/2017, Last updated: 11/05/2017